Works by Eberst, Lauriane

Results: 15
    1

    PARP inhibitors as maintenance therapy in ovarian cancer after platinum-sensitive recurrence: real-world experience from the Unicancer network.

    Published in:
    Oncologist, 2025, v. 30, n. 5, p. 1, doi. 10.1093/oncolo/oyaf075
    By:
    • Rippstein, Nicolas;
    • Zemmour, Christophe;
    • Rodrigues, Manuel;
    • Ray-Coquard, Isabelle;
    • Gladieff, Laurence;
    • Pautier, Patricia;
    • Frénel, Jean-Sébastien;
    • Costaz, Hélène;
    • Lebreton, Coriolan;
    • Pomel, Christophe;
    • Colombo, Pierre-Emmanuel;
    • Marchal, Frédéric;
    • Guillemet, Cécile;
    • Rouge, Thibault de la Motte;
    • Eberst, Lauriane;
    • Bosquet, Lise;
    • Deluche, Elise;
    • Sabatier, Renaud
    Publication type:
    Article
    2
    3

    Clinical outcome of patients with isolated central nervous system progression on first-line pertuzumab and trastuzumab treatment for HER2-positive metastatic breast cancer in a real-life cohort.

    Published in:
    Breast Cancer (13406868), 2023, v. 30, n. 2, p. 329, doi. 10.1007/s12282-022-01427-0
    By:
    • Collet, Laetitia;
    • Eberst, Lauriane;
    • Ludovic, Gauthier;
    • Debled, Marc;
    • Hrab, Loana;
    • Mouret-Reynier, Marie-Ange;
    • Desmoulins, Isabelle;
    • Goncalves, Anthony;
    • Campone, Mario;
    • Ferrero, Jean-Marc;
    • Brain, Etienne;
    • Uwer, Lionel;
    • Eymard, Jean-Christophe;
    • Dieras, Veronique;
    • Simon, Gaetane;
    • Leheurteur, Marianne;
    • Dalenc, Florence;
    • Vanlemmens, Laurence;
    • Darlix, Amelie;
    • Arnedos, Monica
    Publication type:
    Article
    4
    5

    A Phase 1 dose-escalation study to evaluate safety, pharmacokinetics and pharmacodynamics of AsiDNA, a first-in-class DNA repair inhibitor, administered intravenously in patients with advanced solid tumours.

    Published in:
    2020
    By:
    • Le Tourneau, Christophe;
    • Delord, Jean-Pierre;
    • Kotecki, Nuria;
    • Borcoman, Edith;
    • Gomez-Roca, Carlos;
    • Hescot, Ségolène;
    • Jungels, Christiane;
    • Vincent-Salomon, Anne;
    • Cockenpot, Vincent;
    • Eberst, Lauriane;
    • Molé, Audrey;
    • Jdey, Wael;
    • Bono, Françoise;
    • Trochon-Joseph, Véronique;
    • Toussaint, Hélène;
    • Zandanel, Christelle;
    • Adamiec, Olga;
    • de Beaumont, Olivier;
    • Cassier, Philippe Alexandre
    Publication type:
    journal article
    6

    Real-world outcomes of metastatic cancer patients hospitalized at initial diagnosis: ONIRIS, a national study.

    Published in:
    Supportive Care in Cancer, 2025, v. 33, n. 2, p. 1, doi. 10.1007/s00520-025-09202-5
    By:
    • Vercueil, Colin;
    • Varnier, Romain;
    • Seban, Romain;
    • Ciaptacz, Lisa;
    • Pavillet, Julien;
    • Fraisse, Cléa;
    • Darbas, Tiffany;
    • Abdallahoui, Safa;
    • Cox, David;
    • Martin, Sophie;
    • Trensz, Philippe;
    • Kurtz, Jean-Emmanuel;
    • Gantzer, Justine;
    • Amé, Shanti;
    • Bouleuc, Carole;
    • Chvetzoff, Gisèle;
    • Eberst, Lauriane
    Publication type:
    Article
    7

    Uncovering the Translational Regulatory Activity of the Tumor Suppressor BRCA1.

    Published in:
    Cells (2073-4409), 2020, v. 9, n. 4, p. 941, doi. 10.3390/cells9040941
    By:
    • Berthel, Elise;
    • Vincent, Anne;
    • Eberst, Lauriane;
    • Torres, Adrian Gabriel;
    • Dacheux, Estelle;
    • Rey, Catherine;
    • Marcel, Virginie;
    • Paraqindes, Hermes;
    • Lachuer, Joël;
    • Catez, Frédéric;
    • de Pouplana, Lluis Ribas;
    • Treilleux, Isabelle;
    • Diaz, Jean-Jacques;
    • Dalla Venezia, Nicole
    Publication type:
    Article
    8

    Alterations in Homologous Recombination-Related Genes and Distinct Platinum Response in Metastatic Triple-Negative Breast Cancers: A Subgroup Analysis of the ProfiLER-01 Trial.

    Published in:
    Journal of Personalized Medicine, 2022, v. 12, n. 10, p. 1595, doi. 10.3390/jpm12101595
    By:
    • Bonnet, Elise;
    • Haddad, Véronique;
    • Quesada, Stanislas;
    • Baffert, Kim-Arthur;
    • Lardy-Cléaud, Audrey;
    • Treilleux, Isabelle;
    • Pissaloux, Daniel;
    • Attignon, Valéry;
    • Wang, Qing;
    • Buisson, Adrien;
    • Heudel, Pierre-Etienne;
    • Bachelot, Thomas;
    • Dufresne, Armelle;
    • Eberst, Lauriane;
    • Toussaint, Philippe;
    • Bonadona, Valérie;
    • Lasset, Christine;
    • Viari, Alain;
    • Sohier, Emilie;
    • Paindavoine, Sandrine
    Publication type:
    Article
    9
    10
    11

    The off-label use of targeted therapies in sarcomas: the OUTC'S program.

    Published in:
    2014
    By:
    • Eberst, Lauriane;
    • Cropet, Claire;
    • Le Cesne, Axel;
    • Pautier, Patricia;
    • Penel, Nicolas;
    • Adenis, Antoine;
    • Chevreau, Christine;
    • Bay, Jacques-Olivier;
    • Collard, Olivier;
    • Cupissol, Didier;
    • Duffaud, Florence;
    • Gentet, Jean-Claude;
    • Piperno-Neumann, Sophie;
    • Marec-Berard, Perrine;
    • Bompas, Emmanuelle;
    • Thyss, Antoine;
    • Chaigneau, Loic;
    • Cassier, Philippe;
    • Bertucci, François;
    • Blay, Jean-Yves
    Publication type:
    journal article
    12

    The CSF-1R inhibitor pexidartinib affects FLT3-dependent DC differentiation and may antagonize durvalumab effect in patients with advanced cancers.

    Published in:
    Science Translational Medicine, 2024, v. 16, n. 731, p. 1, doi. 10.1126/scitranslmed.add1834
    By:
    • Voissière, Aurélien;
    • Gomez-Roca, Carlos;
    • Chabaud, Sylvie;
    • Rodriguez, Céline;
    • Nkodia, Axelle;
    • Berthet, Justine;
    • Montane, Laure;
    • Bidaux, Anne-Sophie;
    • Treilleux, Isabelle;
    • Eberst, Lauriane;
    • Terret, Catherine;
    • Korakis, Iphigénie;
    • Garin, Gwenaelle;
    • Pérol, David;
    • Delord, Jean-Pierre;
    • Caux, Christophe;
    • Dubois, Bertrand;
    • Ménétrier-Caux, Christine;
    • Bendriss-Vermare, Nathalie;
    • Cassier, Philippe A.
    Publication type:
    Article
    13

    The off-label use of targeted therapies in sarcomas: the OUTC'S program.

    Published in:
    BMC Cancer, 2014, v. 14, n. 1, p. 1, doi. 10.1186/1471-2407-14-870
    By:
    • Eberst, Lauriane;
    • Cropet, Claire;
    • Le Cesne, Axel;
    • Pautier, Patricia;
    • Penel, Nicolas;
    • Adenis, Antoine;
    • Chevreau, Christine;
    • Bay, Jacques-Olivier;
    • Collard, Olivier;
    • Cupissol, Didier;
    • Duffaud, Florence;
    • Gentet, Jean-Claude;
    • Piperno-Neumann, Sophie;
    • Marec-Berard, Perrine;
    • Bompas, Emmanuelle;
    • Thyss, Antoine;
    • Chaigneau, Loic;
    • Cassier, Philippe;
    • Bertucci, François;
    • Blay, Jean-Yves
    Publication type:
    Article
    14

    The off-label use of targeted therapies in sarcomas: the OUTC'S program.

    Published in:
    BMC Cancer, 2014, v. 14, p. 1, doi. 10.1186/1471-2407-14-870
    By:
    • Eberst, Lauriane;
    • Cropet, Claire;
    • Le Cesne, Axel;
    • Pautier, Patricia;
    • Penel, Nicolas;
    • Adenis, Antoine;
    • Chevreau, Christine;
    • Bay, Jacques-Olivier;
    • Collard, Olivier;
    • Cupissol, Didier;
    • Duffaud, Florence;
    • Gentet, Jean-Claude;
    • Piperno-Neumann, Sophie;
    • Marec-Berard, Perrine;
    • Bompas, Emmanuelle;
    • Thyss, Antoine;
    • Chaigneau, Loic;
    • Cassier, Philippe;
    • Bertucci, François;
    • Blay, Jean-Yves
    Publication type:
    Article
    15

    DOMENICA study (GINECO-EN105b/ENGO-Ten13): randomized phase III trial in MMR deficient (MMRd) endometrial cancer (EC) patients comparing chemotherapy (CT) alone versus dostarlimab in first line advanced/metastatic setting (APGOT-EN1).

    Published in:
    Journal of Gynecologic Oncology, 2024, v. 35, p. 19, doi. 10.3802/jgo.2024.35.S2.P1
    By:
    • Chel Hun Choi;
    • Ray-Coquard, Isabelle;
    • Rubio, Maria Jesus;
    • Paoletti, Xavier;
    • Hudson, Emma;
    • Lorusso, Domenica;
    • Hasler-Strub, Ursula;
    • Vardar, Mehmet Ali;
    • Lheureux, Stéphanie;
    • Van Gorp, Toon;
    • Shao Peng Tan, David;
    • Trillsch, Fabian;
    • Eberst, Lauriane;
    • Lescure, Céline;
    • Hardy-Bessard, Anne-Claire;
    • Chaix, Marie;
    • Byoung-Gie Kim;
    • JaeWeon Kim;
    • JeongYeol Park;
    • Jung-Yun Lee
    Publication type:
    Article